In a Worker Adjustment and Retraining Notification Act alert filed this week, Merck revealed that it is laying off 147 staffers at a vaccine manufacturing plant in Durham. The cuts are a result of Merck’s decision to end production of
read moreOn some level, Eli Lilly’s partnership with computing giant Nvidia feels inevitable. The first pharma to reach a $1 trillion valuation teaming up with a tech firm that has ridden the AI wave to a record-setting $5 trillion valuation of
read moreA handful of pharmas and celebrities are joining forces with the National Bleeding Disorders Foundation for a long-lasting awareness push. More: Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign Source: fierce
read moreWhile the FDA has flip-flopped on whether to review Moderna’s combination influenza/COVID-19 vaccine, it’s full speed ahead for the mRNA shot in Europe, with a positive recommendation from the CHMP. More: After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific
read moreTwo years and five indications later, UCB’s immunology blockbuster Bimzelx is halfway to the company’s initial goal of at least 4 billion euros ($4.4 billion) in peak sales. More: UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum
read more© 1994 - 2026 B.M. Pharmaceuticals